Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Biosens Bioelectron ; 237: 115510, 2023 Oct 01.
Article in English | MEDLINE | ID: mdl-37442028

ABSTRACT

Incorporating non-invasive biosensing features in organ-on-chip models is of paramount importance for a wider implementation of these advanced in vitro microfluidic platforms. Optical biosensors, based on Bioluminescence Imaging (BLI), enable continuous, non-invasive, and in-situ imaging of cells, tissues or miniaturized organs without the drawbacks of conventional fluorescence imaging. Here, we report the first-of-its-kind integration and optimization of BLI in microfluidic chips, for non-invasive imaging of multiple biological readouts. The cell line HEK293T-GFP was engineered to express NanoLuc® luciferase under the control of a constitutive promoter and were cultured on-chip in 3D, in standard ECM-like hydrogels, to assess optimal cell detection conditions. Using real-time in-vitro dual-color microscopy, Bioluminescence (BL) and fluorescence (FL) were detectable using distinct imaging setups. Detection of the bioluminescent signals were observed at single cell resolution on-chip 20 min post-addition of Furimazine substrate and under perfusion. All hydrogels enabled BLI with higher signal-to-noise ratios as compared to fluorescence. For instance, agarose gels showed a ∼5-fold greater BL signal over background after injection of the substrate as compared to the FL signal. The use of BLI with microfluidic chip technologies opens up the potential for simultaneous in situ detection with continuous monitoring of multicolor cell reporters. Moreover, this can be achieved in a non-invasive manner. BL has great promise as a highly desirable biosensor for studying organ-on-chip platforms.


Subject(s)
Biosensing Techniques , Humans , HEK293 Cells , Biosensing Techniques/methods , Microfluidics , Microscopy , Optical Imaging
2.
Adv Exp Med Biol ; 1379: 171-203, 2022.
Article in English | MEDLINE | ID: mdl-35760992

ABSTRACT

Organs-on-chips are microfluidic tissue-engineered models that offer unprecedented dynamic control over cellular microenvironments, emulating key functional features of organs or tissues. Sensing technologies are increasingly becoming an essential part of such advanced model systems for real-time detection of cellular behavior and systemic-like events. The fast-developing field of organs-on-chips is accelerating the development of biosensors toward easier integration, thus smaller and less invasive, leading to enhanced access and detection of (patho-) physiological biomarkers. The outstanding combination of organs-on-chips and biosensors holds the promise to contribute to more effective treatments, and, importantly, improve the ability to detect and monitor several diseases at an earlier stage, which is particularly relevant for complex diseases such as cancer. Biosensors coupled with organs-on-chips are currently being devised not only to determine therapy effectiveness but also to identify emerging cancer biomarkers and targets. The ever-expanding use of imaging modalities for optical biosensors oriented toward on-chip applications is leading to less intrusive and more reliable detection of events both at the cellular and microenvironment levels. This chapter comprises an overview of hybrid approaches combining organs-on-chips and biosensors, focused on modeling and investigating solid tumors, and, in particular, the tumor microenvironment. Optical imaging modalities, specifically fluorescence and bioluminescence, will be also described, addressing the current limitations and future directions toward an even more seamless integration of these advanced technologies.


Subject(s)
Biosensing Techniques , Neoplasms , Cellular Microenvironment , Humans , Microfluidics/methods , Neoplasms/diagnosis , Tissue Engineering/methods , Tumor Microenvironment
3.
Adv Healthc Mater ; 11(15): e2102863, 2022 08.
Article in English | MEDLINE | ID: mdl-35596614

ABSTRACT

Clinically relevant in vitro models of human tissue's health and disease are urgently needed for a better understanding of biological mechanisms essential for the development of novel therapies. Herein, physiological (healthy) and pathological (disease) tendon states are bioengineered by coupling the biological signaling of platelet lysate components with controlled 3D architectures of electrospun microfibers to drive the fate of human tendon cells in different composite living fibers (CLFs). In the CLFs-healthy model, tendon cells adopt a high cytoskeleton alignment and elongation, express tendon-related markers (scleraxis, tenomodulin, and mohawk) and deposit a dense tenogenic matrix. In contrast, cell crowding with low preferential orientation, high matrix deposition, and phenotypic drift leading to increased expression of nontendon related and fibrotic markers, are characteristics of the CLFs-diseased model. This diseased-like profile, also reflected in the increase of COL3/COL1 ratio, is further evident by the imbalance between matrix remodeling and degradation effectors, characteristic of tendinopathy. In summary, microengineered 3D in vitro models of human tendon healthy and diseased states are successfully fabricated. Most importantly, these innovative and versatile microphysiological models offer major advantages over currently used systems, holding promise for drugs screening and development of new therapies.


Subject(s)
Tendons , Tissue Engineering , Biomedical Engineering , Cell Differentiation , Humans , Tendons/metabolism
4.
Int J Mol Sci ; 23(6)2022 Mar 09.
Article in English | MEDLINE | ID: mdl-35328370

ABSTRACT

Tendon injuries represent over 30-50% of musculoskeletal disorders worldwide, yet the available therapies do not provide complete tendon repair/regeneration and full functionality restoring. Extracellular vesicles (EVs), membrane-enclosed nanoparticles, have emerged as the next breakthrough in tissue engineering and regenerative medicine to promote endogenous tissue regeneration. Here, we developed a 3D human in vitro model mimicking the signature of pathological tendon and used it to evaluate the influence that different platelet-derived EVs might have in tendon tissue repair mechanisms. For this, different EV populations isolated from platelets, small EVs (sEVs) and medium EVs (mEVs), were added to the culture media of human tendon-derived cells (hTDCs) cultured on isotropic nanofibrous scaffolds. The platelet-derived EVs increased the expression of tenogenic markers, promoted a healthy extracellular matrix (ECM) remodeling, and the synthesis of anti-inflammatory mediators. These findings suggest that platelet EVs provided relevant biochemical cues that potentiated a recovery of hTDCs phenotype from a diseased to a healthy state. Thus, this study opens new perspectives for the translation of platelet-derived EVs as therapeutics.


Subject(s)
Extracellular Vesicles , Musculoskeletal Diseases , Blood Platelets , Extracellular Vesicles/metabolism , Humans , Musculoskeletal Diseases/metabolism , Regenerative Medicine , Tendons
5.
Adv Healthc Mater ; 11(8): e2102076, 2022 04.
Article in English | MEDLINE | ID: mdl-34927396

ABSTRACT

The heterogeneity of hierarchical tissues requires designing multipart engineered constructs as suitable tissue replacements. Herein, the incorporation of platelet lysate (PL) within an electrospun fiber core is proposed aiming for the fabrication of functionally graded 3D scaffolds for heterotypic tissues regeneration, such as tendon-to-bone interfaces. First, anisotropic yarns (A-Yarns) and isotropic threads with nanohydroxyapatite (I-Threads/PL@nHAp) are fabricated to recreate the tendon- and bone-microstructures and both incorporated with PL using emulsion electrospinning for a sustained and local delivery of growth factors, cytokines, and chemokines. Biological performance using human adipose-derived stem cells demonstrates that A-Yarns/PL induce a higher expression of scleraxis, a tenogenic-marker, while in I-Threads/PL@nHAp, higher alkaline phosphatase activity and matrix mineralization suggest an osteogenic commitment without the need for biochemical supplementation compared to controls. As a proof-of-concept, functional 3D gradient scaffolds are fabricated using a weaving technique, resulting in 3D textured hierarchical constructs with gradients in composition and topography. Additionally, the precise delivery of bioactive cues together with in situ biophysical features guide the commitment into a phenotypic gradient exhibiting chondrogenic and osteochondrogenic profiles in the interface of scaffolds. Overall, a promising patch solution for the regeneration of tendon-to-bone tissue interface through the fabrication of PL-functional 3D gradient constructs is demonstrated.


Subject(s)
Tissue Engineering , Tissue Scaffolds , Bone and Bones , Humans , Stem Cells , Tendons/metabolism , Tissue Scaffolds/chemistry
6.
J Cell Physiol ; 236(5): 3991-4007, 2021 05.
Article in English | MEDLINE | ID: mdl-33151579

ABSTRACT

Musculoskeletal interfaces are naturally hypoxic. An understanding of key interactions occurring between different cell populations and their environment is critical for native tissue recapitulation. Here, an enthesis coculture model (preosteoblasts and tendon cells) was used to understand the influence of hypoxia (5% O2 ) and osteogenic medium (OM) supplementation in cells' phenotype modulation. In single cultures, preosteoblasts were found to undergo osteogenic impairment, while tendon cells underwent a maturation process through extracellular matrix (ECM) rescue. When in co-culture, hypoxia and osteoinduction promoted a temporal chondro/osteogenic pathway activation, as observed by an early deposition of cartilaginous ECM associated with HIF1A stabilization and RUNX2 activation, and later hypertrophic differentiation resulting from HIF2A translocation and SOX9 activation. Moreover, the presence of OM under hypoxia was shown to influence the extracellular ROS/HIF1A interplay. Overall, this study revealed a link between biochemical factors and cell-cell crosstalk, providing a molecular framework for hypoxic control and modulation of cells' fate toward enthesis-like phenotypes.


Subject(s)
Chondrocytes/metabolism , Extracellular Matrix/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Osteogenesis , Adult , Aged , Basic Helix-Loop-Helix Transcription Factors/metabolism , Biomarkers/metabolism , Cell Hypoxia , Chondrogenesis , Culture Media , Gene Expression Regulation , Glycosaminoglycans/metabolism , Humans , Middle Aged , Osteoblasts/drug effects , Osteoblasts/metabolism , Protein Stability , Reactive Oxygen Species/metabolism , SOX9 Transcription Factor/metabolism , Signal Transduction , Tenocytes/metabolism , Time Factors
7.
Trends Biotechnol ; 38(1): 83-98, 2020 01.
Article in English | MEDLINE | ID: mdl-31320120

ABSTRACT

Musculoskeletal diseases are increasing the prevalence of physical disability worldwide. Within the body, musculoskeletal soft and hard tissues integrate through specific multitissue transitions, allowing for body movements. Owing to their unique compositional and structural gradients, injuries challenge the native interfaces and tissue regeneration is unlikely to occur. Tissue engineering strategies are emerging to emulate the physiological environment of soft-to-hard tissue interfaces. Advances in biomaterial design enable control over biophysical parameters, but biomaterials alone are not sufficient to provide adequate support and guide transplanted cells. Therefore, biological, biophysical, and biochemical tools can be integrated into a multifactorial toolbox, steering prospective advances toward engineering clinically relevant soft-to-hard tissue interfaces.


Subject(s)
Biophysical Phenomena/physiology , Musculoskeletal Physiological Phenomena , Musculoskeletal System , Software , Tissue Engineering , Animals , Cells, Cultured , Humans , Musculoskeletal System/cytology , Musculoskeletal System/metabolism
8.
Int J Mol Sci ; 20(12)2019 Jun 19.
Article in English | MEDLINE | ID: mdl-31248196

ABSTRACT

Tendon tissues have limited healing capacity. The incidence of tendon injuries and the unsatisfactory functional outcomes of tendon repair are driving the search for alternative therapeutic approaches envisioning tendon regeneration. Cellular therapies aim at delivering adequate, regeneration-competent cell types to the injured tendon and toward ultimately promoting its reconstruction and recovery of functionality. Mesenchymal stem cells (MSCs) either obtained from tendons or from non-tendon sources, like bone marrow (BM-MSCs) or adipose tissue (ASCs), have been receiving increasing attention over the years toward enhancing tendon healing. Evidences from in vitro and in vivo studies suggest MSCs can contribute to accelerate and improve the quality of tendon healing. Nonetheless, the exact mechanisms underlying these repair events are yet to be fully elucidated. This review provides an overview of the main challenges in the field of cell-based regenerative therapies, discussing the role of MSCs in boosting tendon regeneration, particularly through their capacity to enhance the tenogenic properties of tendon resident cells.


Subject(s)
Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/metabolism , Regeneration , Tendon Injuries/therapy , Tendons/cytology , Tendons/metabolism , Animals , Cell Differentiation , Cell- and Tissue-Based Therapy , Humans , Regenerative Medicine , Tendon Injuries/etiology , Tissue Engineering
9.
Adv Healthc Mater ; 8(15): e1900200, 2019 08.
Article in English | MEDLINE | ID: mdl-31190369

ABSTRACT

Tendon-to-bone interfaces exhibit a hierarchical multitissue transition. To replicate the progression from mineralized to nonmineralized tissue, a novel 3D fibrous scaffold is fabricated with spatial control over mineral distribution and cellular alignment. For this purpose, wet-spun continuous microfibers are produced using polycaprolactone (PCL)/ gelatin and PCL/gelatin/hydroxyapatite nano-to-microparticles (HAp). Higher extrusion rates result in aligned PCL/gelatin microfibers while, in the case of PCL/gelatin/HAp, the presence of minerals leads to a less organized structure. Biological performance using human adipose-derived stem cells (hASCs) demonstrates that topography of PCL/gelatin microfibers can induce cytoskeleton elongation, resembling native tenogenic organization. Matrix mineralization on PCL/gelatin/HAp wet-spun composite microfibers suggest the production of an osteogenic-like matrix, without external addition of osteogenic medium supplementation. As proof of concept, a 3D gradient structure is produced by assembling PCL/gelatin and PCL/gelatin/HAp microfibers, resulting in a fibrous scaffold with a continuous topographical and compositional gradient. Overall, the feasibility of wet-spinning for the generation of continuously aligned and textured microfibers is demonsrated, which can be further assembled into more complex 3D gradient structures to mimic characteristic features of tendon-to-bone interfaces.


Subject(s)
Tissue Engineering , Tissue Scaffolds/chemistry , Biomimetic Materials/chemistry , Biomimetic Materials/pharmacology , Bone and Bones/drug effects , Bone and Bones/metabolism , Cell Culture Techniques/methods , Cell Survival/drug effects , Durapatite/chemistry , Extracellular Matrix/chemistry , Extracellular Matrix/drug effects , Extracellular Matrix/metabolism , Gelatin/chemistry , Humans , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/metabolism , Polyesters/chemistry , Tendons/drug effects , Tendons/metabolism , Tensile Strength , Textiles
10.
Tissue Eng Part B Rev ; 25(4): 330-356, 2019 08.
Article in English | MEDLINE | ID: mdl-31038006

ABSTRACT

IMPACT STATEMENT: The main goal of this review is to give an overview of cell-based and tissue engineered strategies for tendon-to-bone interface. The essential role of cells in tendon-to-bone interface development, healing, and regeneration, is underpinned by the physiological status of the junction. Therefore, recent studies underlining the effect of oxygen concentration and production of growth factors are reviewed. A critical view is made on the use of two-dimensional versus three-dimensional culture systems and mechanical stimulation. An overview of advances on bioengineered strategies in light of the biological/cellular requirements of enthesis will contribute to innovations in tendon-to-bone engineering and regeneration.


Subject(s)
Bone and Bones/cytology , Intercellular Signaling Peptides and Proteins/metabolism , Regeneration , Tendons/cytology , Tissue Engineering/methods , Tissue Scaffolds , Animals , Bone and Bones/metabolism , Humans , Tendons/metabolism , Wound Healing
11.
Biomed Mater ; 14(3): 034104, 2019 04 05.
Article in English | MEDLINE | ID: mdl-30844766

ABSTRACT

To engineer functional tissue substitutes, it is required a multi-component, multi-scale approach that combines both physical, chemical and biological cues. Fiber-based techniques have been explored in the field of tissue engineering to produce structures recapitulating tissue architecture and mechanical properties. In this work, we engineered biofunctional composite living fibers (CLF) as multi-compartment fibers with a mechanically competent core and a hydrogel layer. For this purpose, commercial silk suture threads were coated with a platelet lysate (PL) hydrogel by first embedding the threads in a thrombin solution and then incubating in PL. The fabrication set-up was optimized and the biological performance was studied by encapsulating human adipose-derived stem cells (hASCs). The developed coating process rendered CLF with a homogenous PL hydrogel layer covering suture threads. Encapsulated hASCs were viable up to 14 d in culture and were able to align at the surface of the core fiber and deposit collagen types I and III. In summary, the study shows that PL-hASCs hydrogel coated suture threads represent a simple multi-compartment and multifunctional system, with PL hydrogel offering biofunctionality to guide the biological activities of encapsulated cells in addition to the replication of tissue-level mechanical support provided by the suture threads.


Subject(s)
Biocompatible Materials/chemistry , Blood Platelets/chemistry , Hydrogels/chemistry , Tissue Engineering/methods , Adipocytes , Adipose Tissue/cytology , Animals , Cattle , Cell Culture Techniques , Cell Survival , Collagen , Humans , Silk , Stem Cells/cytology , Sutures , Thrombin/chemistry , Tissue Scaffolds/chemistry , Wound Healing
12.
Adv Exp Med Biol ; 1144: 71-90, 2019.
Article in English | MEDLINE | ID: mdl-30632116

ABSTRACT

The complex heterogeneous cellular environment found in tendon-to-bone interface makes this structure a challenge for interface tissue engineering. Orthopedic surgeons still face some problems associated with the formation of fibrotic tissue or re-tear occurring after surgical re-attachment of tendons to the bony insertion or the application of grafts. Unfortunately, an understanding of the cellular component of enthesis lags far behind of other well-known musculoskeletal interfaces, which blocks the development of new treatment options for the healing and regeneration of this multifaceted junction. In this chapter, the main characteristics of tendon and bone cell populations are introduced, followed by a brief description of the interfacial cellular niche, highlighting molecular mechanisms governing tendon-to-bone attachment and mineralization. Finally, we describe and critically assess some challenges faced concerning the use of cell-based strategies in tendon-to-bone healing and regeneration.


Subject(s)
Bone and Bones/cytology , Tendons/cytology , Tissue Engineering , Humans , Wound Healing
13.
J Cell Physiol ; 233(7): 5383-5395, 2018 07.
Article in English | MEDLINE | ID: mdl-29215729

ABSTRACT

Tendon injuries constitute an unmet clinical challenge owing to the limited intrinsic regenerative ability of this tissue. Cell-based therapies aim at improving tendon healing through the delicate orchestration of tissue rebuilding and regain of function. Hence, human adipose-derived stem cells (hASCs) have been proposed as a promising cell source for boosting tendon regeneration. In this work, we investigated the influence of hASCs on native human tendon-derived cells (hTDCs) through the establishment of a direct contact co-culture system. Results demonstrated that direct interactions between these cell types resulted in controlled proliferation and spontaneous cell elongation. ECM-related genes, particularly COL1A1 and TNC, and genes involved in ECM remodeling, such as MMP1, MMP2, MMP3, and TIMP1, were expressed in co-culture in a temporally regulated manner. In addition, deposition of collagen type I was accelerated in co-culture systems and favored over the production of collagen type III, resulting in an enhanced COL1/COL3 ratio as soon as 7 days. In conclusion, hASCs seem to be good candidates in modulating the behavior of native tendon cells, particularly through a balanced process of ECM synthesis and degradation.


Subject(s)
Cell Differentiation/genetics , Extracellular Matrix/genetics , Stem Cells/cytology , Tendons/growth & development , Adipocytes/cytology , Adipocytes/metabolism , Adipose Tissue/cytology , Cell Proliferation/genetics , Cell Survival/genetics , Collagen Type I/genetics , Collagen Type I, alpha 1 Chain , Collagen Type III/genetics , Gene Expression Regulation, Neoplastic/genetics , Humans , Matrix Metalloproteinase 1/genetics , Tenascin/genetics , Tissue Engineering , Tissue Inhibitor of Metalloproteinase-1/genetics
14.
Am J Physiol Renal Physiol ; 313(2): F388-F403, 2017 Aug 01.
Article in English | MEDLINE | ID: mdl-28446460

ABSTRACT

The direct detrusor relaxant effect of ß3-adrenoceptor agonists as a primary mechanism to improve overactive bladder symptoms has been questioned. Among other targets, activation of ß3-adrenoceptors downmodulate nerve-evoked acetylcholine (ACh) release, but there is insufficient evidence for the presence of these receptors on bladder cholinergic nerve terminals. Our hypothesis is that adenosine formed from the catabolism of cyclic AMP in the detrusor may act as a retrograde messenger via prejunctional A1 receptors to explain inhibition of cholinergic activity by ß3-adrenoceptors. Isoprenaline (1 µM) decreased [3H]ACh release from stimulated (10 Hz, 200 pulses) human (-47 ± 5%) and rat (-38 ± 1%) detrusor strips. Mirabegron (0.1 µM, -53 ± 8%) and CL316,243 (1 µM, -37 ± 7%) mimicked isoprenaline (1 µM) inhibition, and their effects were prevented by blocking ß3-adrenoceptors with L748,337 (30 nM) and SR59230A (100 nM), respectively, in human and rat detrusor. Mirabegron and isoprenaline increased extracellular adenosine in the detrusor. Blockage of A1 receptors with 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 100 nM) or the equilibrative nucleoside transporters (ENT) with dipyridamole (0.5 µM) prevented mirabegron and isoprenaline inhibitory effects. Dipyridamole prevented isoprenaline-induced adenosine outflow from the rat detrusor, and this effect was mimicked by the ENT1 inhibitor, S-(4-nitrobenzyl)-6-thioinosine (NBTI, 30 µM). Cystometry recordings in anesthetized rats demonstrated that SR59230A, DPCPX, dipyridamole, and NBTI reversed the decrease in the voiding frequency caused by isoprenaline (0.1-1,000 nM). Data suggest that inhibition of cholinergic neurotransmission by ß3-adrenoceptors results from adenosine release via equilibrative nucleoside transporters and prejunctional A1-receptor stimulation in human and rat urinary bladder.


Subject(s)
Acetylcholine/metabolism , Adenosine/metabolism , Cholinergic Fibers/metabolism , Neural Inhibition , Presynaptic Terminals/metabolism , Receptor, Adenosine A1/metabolism , Receptors, Adrenergic, beta-3/metabolism , Synaptic Transmission , Urinary Bladder/innervation , Adenosine A1 Receptor Antagonists/pharmacology , Adrenergic beta-3 Receptor Agonists/pharmacology , Adrenergic beta-3 Receptor Antagonists/pharmacology , Adult , Animals , Cholinergic Fibers/drug effects , Cyclic AMP/metabolism , Equilibrative Nucleoside Transport Proteins/metabolism , Humans , In Vitro Techniques , Male , Middle Aged , Neural Inhibition/drug effects , Phosphodiesterase Inhibitors/pharmacology , Presynaptic Terminals/drug effects , Rats, Wistar , Receptor, Adenosine A1/drug effects , Receptors, Adrenergic, beta-3/drug effects , Synaptic Transmission/drug effects , Time Factors , Urination , Urodynamics
15.
Talanta ; 148: 486-93, 2016 Feb 01.
Article in English | MEDLINE | ID: mdl-26653476

ABSTRACT

A new and simple analytical approach consisting of an automated headspace solid-phase microextraction (HS-SPME) sampler coupled to gas chromatography-ion trap/mass spectrometry detection (GC-IT/MS) with a prior derivatization step with O-(2,3,4,5,6-pentafluorobenzyl)hydroxylamine hydrochloride (PFBHA) was developed to detect volatile carbonyl metabolites with low molecular weights in human urine. A central composite design (CCD) was used to optimise the PFBHA concentration and extraction conditions that affect the efficiency of the SPME procedure. With a sample volume of 1 mL, optimal conditions were achieved by adding 300 mg/L of PFBHA and allowing the sample to equilibrate for 6 min at 62°C and then extracting the samples for 51 min at the same temperature, using a divinylbenzene/polydimethylsiloxane (DVB/PDMS) fibre. The method allowed the simultaneous identification and quantification of 44 carbonyl compounds consisting of aldehydes, dialdehydes, heterocyclic aldehydes and ketones. The method was validated with regards to the linearity, inter- and intra-day precision and accuracy. The detection limits ranged from 0.009 to 0.942 ng/mL, except for 4-hydroxy-2-nonenal (15 ng/mL), and the quantification limits varied from 0.029 to 1.66 ng/mL, except for butanal (2.78 ng/mL), 2-butanone (2.67 ng/mL), 4-heptanone (3.14 ng/mL) and 4-hydroxy-2-nonenal (50.0 ng/mL). The method accuracy was satisfactory, with recoveries ranging from 90 to 107%. The proof of applicability of the methodology was performed in a pilot target analysis of urine samples obtained from 18 healthy smokers and 18 healthy non-smokers (control group). Chemometric supervised analysis was performed using the volatile patterns acquired for these samples and clearly showed the potential of the volatile carbonyl profiles to discriminate urine from smoker and non-smoker subjects. 5-Methyl-2-furfural (p<0.0001), 2-methylpropanal, nonanal and 2-methylbutanal (p<0.05) were identified as potentially useful biomarkers to identify smoking habits.


Subject(s)
Gas Chromatography-Mass Spectrometry/standards , Smoking/urine , Solid Phase Microextraction/standards , Volatile Organic Compounds/urine , Adult , Aldehydes/urine , Biomarkers/urine , Female , Humans , Hydroxylamines/urine , Ketones/urine , Male , Middle Aged , Pilot Projects , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...